Literature DB >> 9567346

Differentiation and breast cancer.

J Russo1, I H Russo.   

Abstract

The mammary gland is an organ whose size, shape and function undergo fundamental changes during the various phases of a woman's growth. Although the development of the mammary gland begins during infancy, the most dramatic changes occur with the initiation of puberty. Pregnancy and lactation complete the functional development of the organ, which regresses during menopause. Epidemiological and experimental studies have demonstrated that certain hormonal influences, especially those related to reproduction, modify the risk of developing breast cancer. Thus, a full term pregnancy completed before the age of 24 years significantly reduces the lifetime incidence of breast cancer. Although the mechanism through which pregnancy protects the breast from breast cancer has not been clearly established, experimental models of mammary carcinogenesis have allowed researchers to determine that pregnancy inhibits the initiation of the neoplastic process through the induction of a complete differentiation of the mammary gland. This process activates specific genes, which in turn modify the response of the organ to ulterior hormonal changes. It is postulated that the same mechanism might be responsible for the protective effect of a woman's early first full term pregnancy. The greater incidence of breast cancer observed in nulliparous women correlates well with the greater susceptibility of the virgin rat to develop mammary carcinomas when exposed to chemical carcinogens. The successful induction of malignant transformation in the virgin animal mammary epithelium is due to the presence of undifferentiated structures with a high rate of cell proliferation. These structures are eliminated by pregnancy. The breast of nulliparous women retains those undifferentiated structures, which increase the predisposition of the organ to undergo malignant transformation, which will manifest itself clinically several years after its initiation. The correlation of human epidemiological, clinical and experimental data with those data obtained in rodent experimental models lends support to this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9567346

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  15 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

2.  Multiple births and breast cancer prognosis: a population based study.

Authors:  Lukman Thalib; Suhail A R Doi; Per Hall
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Reproductive history and risk of three breast cancer subtypes defined by three biomarkers.

Authors:  Amanda I Phipps; Diana S M Buist; Kathleen E Malone; William E Barlow; Peggy L Porter; Karla Kerlikowske; Christopher I Li
Journal:  Cancer Causes Control       Date:  2010-12-24       Impact factor: 2.506

4.  Bone Density and Timing of Puberty in a Longitudinal Study of Girls.

Authors:  Ashley M Cattran; Heidi J Kalkwarf; Susan M Pinney; Bin Huang; Frank M Biro
Journal:  J Pediatr Adolesc Gynecol       Date:  2014-07-19       Impact factor: 1.814

5.  Estrogen receptors alpha and beta in the rodent mammary gland.

Authors:  S Saji; E V Jensen; S Nilsson; T Rylander; M Warner; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Reproductive history and risk of colorectal cancer in postmenopausal women.

Authors:  Alice Zervoudakis; Howard D Strickler; Yikyung Park; Xiaonan Xue; Albert Hollenbeck; Arthur Schatzkin; Marc J Gunter
Journal:  J Natl Cancer Inst       Date:  2011-03-29       Impact factor: 13.506

7.  Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival.

Authors:  Marilyn L Kwan; Philip S Bernard; Candyce H Kroenke; Rachel E Factor; Laurel A Habel; Erin K Weltzien; Adrienne Castillo; Erica P Gunderson; Kaylynn S Maxfield; Inge J Stijleman; Bryan M Langholz; Charles P Quesenberry; Lawrence H Kushi; Carol Sweeney; Bette J Caan
Journal:  J Natl Cancer Inst       Date:  2015-04-28       Impact factor: 13.506

Review 8.  Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Authors:  Frederik Holst
Journal:  World J Clin Oncol       Date:  2016-04-10

9.  Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis.

Authors:  Yogi Misra; Pamela A Bentley; Jeffrey P Bond; Scott Tighe; Timothy Hunter; Feng-Qi Zhao
Journal:  Physiol Genomics       Date:  2011-11-15       Impact factor: 3.107

10.  p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis.

Authors:  L Sivaraman; O M Conneely; D Medina; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.